Experiment 2: Concepts of Quality Control and Safety in Serologic Testing Flashcards

1
Q

Refers to the overall process of guaranteeing quality patient care and is regulated throughout the total testing system

A

QUALITY ASSESSMENT or QUALITY ASSURANCE (QA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

are the variables that occur before the actual testing of the specimen

A

Pre-analytical factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pre-analytical factors

A

• Test request
• Patient preparation
• Specimen collection, handling, and storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

are the processes that directly affect the testing of specimens.

A

Analytical factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Analytical factors

A

• Reagents • Instrumentation and equipment: instrument calibration and maintenance • Testing procedure • Preventive maintenance • Access to procedure manuals • Competency of personnel performing the tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

o Refers to the materials, procedures, and techniques that monitor the accuracy, precision, and reliability of a laboratory test

A

Quality Control (QC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

are performed to ensure that acceptable standards are met during the process of patient testing

A

o QC procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

• Used to verify the accuracy and precision of a test and are exposed to the same conditions as the patient samples.

is the ability to maintain both precision and accuracy

A

External quality controls

Reliability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

(ability to obtain the expected result)

A

accuracy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

(ability to obtain the same result on the same specimen)

A

precision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

consists of internal monitoring systems built into the test system

A

Internal quality control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

controls monitor the correct addition of a patient specimen or reagent, the instruments/reagents interaction, and test completion

A

• Internal or procedural

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

monitor a test system’s electronic or electric components

A

• Electronic controls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

• The testing of unknown samples received from an outside agency

A

Proficiency testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

• It provides unbiased validation of the quality of patient test results

A

Proficiency testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

are processes that affect the reporting of results and correct interpretation of data.

A

Post-analytical factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How close measurement is to true value

A

o Accuracy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How close results are when same sample is tested multiple times

A

o Precision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Range of values over which laboratory can verify accuracy of test system

A

o Reportable range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Formerly called normal value

A

o Reference interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lowest concentration of substance that can be detected by test method

A

o Analytical sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Ability of method to measure only analyte it is supposed to measure and not other related substances

A

o Analytical specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

• Process of testing and adjusting analyzer’s readout to establish correlation between measured and actual concentrations

A

o Calibration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

• Reference material with known concentration of analyte

A

o Calibrator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

• Testing materials of known concentrations (calibrators, controls, proficiency testing samples, patient specimens with known values) to ensure accuracy of results throughout reportable range

A

o Calibration verification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

• Test three (3) levels: high, midpoint, and low

A

o Calibration verification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

• Required every 6 months, when lot number of reagents changes, following preventive maintenance or repair, and when controls are out of range

A

o Calibration verification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Positive results in a patient who has the disease

A

True Positive (TP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Positive results in a patient who does not have the disease

A

False Positive (FP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Negative results in a patient who does not have the disease

A

True Negative (TN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Negative results in a patient who has the disease

A

False Negative (FN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

% of population with the disease that test positive

A

Diagnostic sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

% of population without the disease that test negative

A

Diagnostic specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

% of time that a pos itive result is corr ect

A

Positive predictive value (PPV)

35
Q

% of time that a negative result is correct

A

Negative predictive value (NPV)

36
Q

Study to verify accuracy of new method

A

o Correlation study

37
Q

Schedule of maintenance to keep equipment in peak operating condition

A

o Preventive maintenance

38
Q

Procedures specified by manufacturer to evaluate critical operating characteristics of test system

A

o Function checks

39
Q

Comparison of patient data with previous results

A

o Delta checks

40
Q

Other Components of QA Program

A

o Correlation study
o Preventive maintenance
o Function checks
o Delta checks

41
Q

Study to verify accuracy of new method

A

o Correlation study

42
Q

Schedule of maintenance to keep equipment in peak operating condition

A

o Preventive maintenance

43
Q

Procedures specified by manufacturer to evaluate critical operating characteristics of test system

A

o Function checks

44
Q

Comparison of patient data with previous results

A

o Delta checks

45
Q

Types of Safety Hazard

A

Biological
Sharp
Chemical
Radioactive
Electrical
Fire/explosive
Physical

46
Q

Infectious agents

A

Biological

47
Q

Bacterial, fungal, viral or parasitic infections

A

Biological

48
Q

Needles, lancets, and broken glass

A

Sharp

49
Q

Cuts, punctures, or blood-borne pathogen exposure

A

Sharp

50
Q

Preservatives and reagents

A

Chemical

51
Q

Exposure to toxic carcinogenic or caustic agents

A

Chemical

52
Q

Equipment and radioisotopes

A

Radioactive

53
Q

Radiation exposure

A

Radioactive

54
Q

Ungrounded or wet equipment and frayed cords

A

Electrical

55
Q

Burns or shock

A

Electrical

56
Q

Bunsen burners and organic chemicals

A

Fire/explosive

57
Q

Burns or dismemberment

A

Fire/explosive

58
Q

Wet floors, heavy boxes and patients

A

Physical

59
Q

Falls, sprains and strains

A

Physical

60
Q

o Denotes infectious materials or agents that present a potential health risk

A

BIOHAZARD/Biological Health Hazard

61
Q

o Chain of infection and safety practices related to the

A

biohazard symbol

62
Q

o Concern over exposure to blood-borne pathogens resulted in the drafting of guidelines and regulations by the (?) and the (?) to prevent exposure

A

Centers for Disease Control and Prevention (CDC)
Occupational Safety and Health Administration (OSHA)

63
Q

The (?) guidelines describe four levels of biosafety depending upon the biological agents isolated or studied.

A

National Institutes of Health

64
Q

The (?) are based on the virulence of the agents and the availability of effective treatments and vaccines

A

four levels of biosafety

65
Q

laboratories handle agents that have no known potential for infecting healthy people.

A
  1. Biosafety Level 1 laboratories
66
Q

are those laboratories that work with microorganisms associated with human diseases that are rarely serious and for which preventive or therapeutic interventions are often available.

A
  1. Biosafety Level 2 laboratories
67
Q

is recommended for materials that may contain viruses not normally encountered in a clinical laboratory and for the cultivation of mycobacteria. Working with mycobacteria requires the use of N95 HEPA filter respirators.

A
  1. Biosafety Level 3
68
Q

is required for work with dangerous and exotic agents that pose a high risk of aerosol-transmitted laboratory infections and life-threatening diseases for which effective treatments are limited.

A
  1. Biosafety Level 4
69
Q

Exposure risks

A

• Accidental punctures with needles
• Spraying (aerosols) or spilling infectious materials onto desktop or floor
• Cuts or scratches from contaminated objects
• Centrifuge accidents: aerosols, broken tubes, etc.

70
Q

all patients are considered to be possible carriers of blood-borne pathogens

A

o Universal Precautions (UP)

71
Q

These guidelines are not limited to blood-borne pathogens; they consider all body fluids and moist body substances to be potentially infectious

A

Body Substance Isolation (BSI)

72
Q

• Guideline describing personnel protective practices

A

Standard Precaution

73
Q

o The guideline recommends wearing gloves when collecting or handling blood and body fluids contaminated with blood and wearing face shields when there is danger of blood splashing on mucous membranes and when disposing of all needles and sharp objects in puncture-resistant containers

A

Universal Precautions (UP)

74
Q

o The CDC excluded urine and body fluids not visibly contaminated by blood, although many specimens can contain a considerable amount of blood before it becomes visible

A

Universal Precautions (UP)

75
Q

personnel should wear gloves at all times when encountering moist body substances.

A

Body Substance Isolation (BSI)

76
Q

o A major disadvantage is that they do not recommend handwashing following removal of gloves unless visual contamination is present

A

Body Substance Isolation (BSI)

77
Q

o Present a serious biological hazard, particularly for the transmission of blood-borne pathogens

A

SHARP HAZARDS

78
Q

Specimens that are POTENTIALLY infectious

A

o Blood
o Pus and purulent fluids
o Semen
o Vaginal secretions
o Cerebrospinal fluid
o Pleural fluid
o Peritoneal fluid
o Pericardial fluid
o Amniotic fluid
o Breast milk

79
Q

Specimens that are usually NOT infectious (unless visibly bloody)

A

o Feces
o Nasal secretions
o Sputum
o Sweat
o Tears
o Urine
o Vomitus

80
Q

is a law monitored and enforced by OSHA.

A

Occupational Exposure to Blood-Borne Pathogens Standard

81
Q

Specific requirements of this OSHA standard include the following:
1. Requiring all employees to practice (?)
2. Providing laboratory coats, gowns, face and respiratory protection, and (?) gloves to employees and for nondisposable protective clothing
3. Providing (?) and prohibiting recapping of needles
4. Prohibiting eating, drinking, smoking, and (?), lip balm, and contact lens in the work area
5. Labeling all (?) material and containers
6. Providing free immunization for (?)
7. Establishing a (?) for work surfaces; an appropriate disinfectant for blood-borne pathogens is
8. Providing (?) for employees who have been accidentally exposed to blood-borne pathogens
9. Documenting (?) in safety standards for employees

A

UP/Standard Precautions
laundry facilities
sharps disposal containers
applying cosmetics
biohazardous
HBV
daily disinfection protocol
medical follow-up
regular training

82
Q

§ Any accidental exposure to a possible blood-borne pathogen must be

A

immediately reported

83
Q

§ Evaluation of the incident must begin right away to ensure appropriate

A

post-exposure prophylaxis (PEP)